A detailed history of Menora Mivtachim Holdings Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Menora Mivtachim Holdings Ltd. holds 1,556,813 shares of ABBV stock, worth $273 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares
1,556,813
Previous 1,539,609 1.12%
Holding current value
$273 Million
Previous $264 Million 16.42%
% of portfolio
1.97%
Previous 1.82%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $2.82 Million - $3.43 Million
17,204 Added 1.12%
1,556,813 $307 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $57.6 Million - $65.7 Million
360,664 Added 30.59%
1,539,609 $280 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $37.7 Million - $42.5 Million
274,000 Added 30.28%
1,178,945 $183 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $2.19 Million - $2.54 Million
-16,400 Reduced 1.78%
904,945 $135 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $397,530 - $494,700
-3,000 Reduced 0.32%
921,345 $124 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $1.02 Million - $1.17 Million
-7,025 Reduced 0.75%
924,345 $147 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $25.3 Million - $31.4 Million
192,050 Added 25.98%
931,370 $151 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $319,200 - $362,340
3,000 Added 0.41%
739,320 $79.8 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $77.3 Million - $85.1 Million
-755,280 Reduced 50.64%
736,320 $79.7 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $27.6 Million - $37.2 Million
342,600 Added 29.82%
1,491,600 $160 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $46.7 Million - $54.9 Million
544,000 Added 89.92%
1,149,000 $101 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $44.4 Million - $59.4 Million
605,000 New
605,000 $59.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Menora Mivtachim Holdings Ltd. Portfolio

Follow Menora Mivtachim Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.